NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials

NZ start-up's ginger-based rheumatoid arthritis therapy in clinical trials
Evithé Biotechnology founder Cynthia Hunefeld. (Image: Supplied)
Greg Hurrell
A New Zealand start-up is carrying out phase one clinical trials of its rheumatoid arthritis therapy based on the ginger plant.Evithé Biotechnology is a spinout company from Victoria University developing botanical and multi-target pharmaceutical prescription drugs from ginger rhizomes.Beyond rheumatoid arthritis, the company has a pipeline of botanical and pharmaceutical prescription drugs that could get to the root of other inflammatory disorders such as Alzheimer’s disease and sepsis.It hopes to have its first therapies on the m...

More Editor's Picks

Small Cap Wrap: It's all about AGMs
Markets

Small Cap Wrap: It's all about AGMs

Burger Fuel's covid hangover and court costs, Third Age, Solution Dynamics, and more.

How rising house prices hurt productivity
Editor's Picks Housing

How rising house prices hurt productivity

Luxon is hoping house prices rise, but productivity may not follow.

Dileepa Fonseka 28 Aug 2025
Spanish infra giant Acciona backs Clifford Bay
Infrastructure

Spanish infra giant Acciona backs Clifford Bay

The upstart ferry port challenger boasts heavy-hitting backers.

Pattrick Smellie 27 Aug 2025
Fonterra spinoff's $3.2b capital return
Primary Sector

Fonterra spinoff's $3.2b capital return

Farmers will vote on the $4b deal in October.

Riley Kennedy 26 Aug 2025